Maladaptive Modulations of NLRP3 Inflammasome and Cardioprotective Pathways Are Involved in Diet-Induced Exacerbation of Myocardial Ischemia/Reperfusion Injury in Mice

Oxidative Medicine and Cellular Longevity
Raffaella MastrocolaManuela Aragno

Abstract

Excessive fatty acids and sugars intake is known to affect the development of cardiovascular diseases, including myocardial infarction. However, the underlying mechanisms are ill defined. Here we investigated the balance between prosurvival and detrimental pathways within the heart of C57Bl/6 male mice fed a standard diet (SD) or a high-fat high-fructose diet (HFHF) for 12 weeks and exposed to cardiac ex vivo ischemia/reperfusion (IR) injury. Dietary manipulation evokes a maladaptive response in heart mice, as demonstrated by the shift of myosin heavy chain isoform content from α to β, the increased expression of the Nlrp3 inflammasome and markers of oxidative metabolism, and the downregulation of the hypoxia inducible factor- (HIF-)2α and members of the Reperfusion Injury Salvage Kinases (RISK) pathway. When exposed to IR, HFHF mice hearts showed greater infarct size and lactic dehydrogenase release in comparison with SD mice. These effects were associated with an exacerbated overexpression of Nlrp3 inflammasome, resulting in marked caspase-1 activation and a compromised activation of the cardioprotective RISK/HIF-2α pathways. The common mechanisms of damage here reported lead to a better understanding of the cross-talk among ...Continue Reading

References

Mar 4, 2000·The New England Journal of Medicine·S H LeeP A Thistlethwaite
Jul 4, 2003·Current Opinion in Lipidology·Jean E Schaffer
Jul 13, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jan Steffen JürgensenKai-Uwe Eckardt
Jan 21, 2006·Journal of Forensic Sciences·José Blanco PampínRafael Hinojal Fonseca
Mar 9, 2007·Journal of the American Society of Nephrology : JASN·Ichiro KojimaMasaomi Nangaku
Jun 2, 2007·Heart Failure Reviews·Derek J Hausenloy, Derek M Yellon
May 16, 2008·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Alan A Wanderer
Jun 17, 2009·Molecular and Cellular Biology·Erinn B RankinVolker H Haase
Dec 22, 2009·Nature Immunology·Rongbin ZhouJürg Tschopp
Jan 21, 2010·Physiological Reviews·Gary D LopaschukWilliam C Stanley
Jul 24, 2010·Antioxidants & Redox Signaling·Pasquale PagliaroClaudia Penna
Jan 11, 2011·Nature Medicine·Bolormaa VandanmagsarVishwa Deep Dixit
Aug 5, 2011·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Lakshmi PulakatJames R Sowers
Nov 23, 2011·Proceedings of the National Academy of Sciences of the United States of America·Eleonora MezzaromaAntonio Abbate
Jul 18, 2012·Pharmacology & Therapeutics·Sang-Ging Ong, Derek J Hausenloy
Aug 15, 2012·Immunological Reviews·Cees J TackMihai G Netea
Oct 17, 2012·Cardiovascular Diabetology·Manuela AragnoGiampiero Muccioli
Jul 12, 2013·Mediators of Inflammation·Elisa BenettiMassimo Collino
Jul 23, 2013·American Journal of Physiology. Heart and Circulatory Physiology·Joe WuGary L Wright
Dec 18, 2013·Journal of Cardiovascular Pharmacology·Carlo MarchettiAntonio Abbate
Apr 20, 2014·International Journal of Endocrinology·J Fuentes-AntrásO Lorenzo
Sep 10, 2014·Cardiovascular Diabetology·Ruduwaan SalieAmanda Lochner
Oct 21, 2014·Antioxidants & Redox Signaling·Stefano ToldoAntonio Abbate
Nov 8, 2014·Arteriosclerosis, Thrombosis, and Vascular Biology·Fumitake UsuiMasafumi Takahashi
Feb 20, 2015·American Journal of Physiology. Renal Physiology·Yibo ZhuangAihua Zhang

❮ Previous
Next ❯

Citations

Dec 24, 2018·Cardiovascular Research·Coert J ZuurbierSean M Davidson
Aug 17, 2019·American Journal of Physiology. Heart and Circulatory Physiology·Paras K MishraTakashi Matsui
Nov 27, 2019·British Journal of Pharmacology·Ioanna AndreadouPéter Ferdinandy
Mar 11, 2020·Journal of Cellular and Molecular Medicine·Sean M DavidsonUNKNOWN EU-CARDIOPROTECTION COST Action (CA16225)
Mar 26, 2019·Current Medicinal Chemistry·Saveria FemminòClaudia Penna
Aug 11, 2020·British Journal of Pharmacology·Ilaria BertocchiMassimo Collino
Aug 10, 2017·Frontiers in Physiology·Beibei LuoYan He
Aug 28, 2020·Frontiers in Immunology·Benoit Pourcet, Hélène Duez
Aug 26, 2020·The Journal of Allergy and Clinical Immunology·Hugo Charles-MessanceHelen M Roche
Oct 29, 2017·Immunology Letters·Zahra SepehriSaeid Ghavami
Jun 4, 2021·Journal of Inflammation Research·Andrea De LorenzoEduardo Tibirica
Oct 6, 2020·JACC. Basic to Translational Science·Milton Packer
Jun 15, 2021·Cardiology Research and Practice·Kornela HałuchaIwona Bil-Lula

❮ Previous
Next ❯

Methods Mentioned

BETA
enzyme-linked immunosorbent assay
dissect

Software Mentioned

GraphPad
One
GraphPad Prism
Quantity

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Autophagy & Aging: Inhibitors

The feed focuses on the role of nuclear export inhibitors and their effect on autophagy and the aging process.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.